Skip to main content

ATM splicing defect

Individuals with mutations in the ATM gene develop ataxia-telangiectasia, a neurodegenrative disorder characterized by immunological defects and cancer predisposition. In an Advanced Online Publication from Nature Genetics, Pagani et al. describe a new kind of ATM mutation that leads to an unusual splicing defect (11 March 2002, DOI:10.1038/ng858). The mutant ATM allele contains a four-nucleotide deletion (GTAA) within intron 20. This deletion results in the inclusion of a 65 nucleotide 'cryptic exon' in the ATM mRNA. The ATM sequence, termed intron-splicing processing element (ISPE), is complementary to U1 snRNA. Experiments with a hybrid minigene confirmed the importance of the ISPE sequence; and interaction with U1 snRNA affected the efficiency of intron removal. Introduction of the ISPE sequence into a different genomic context, exon 9 of the cystic fibrosis transmembrane regulator (CFTR) gene, caused exon skipping and splicing defects.


  1. The genetic defect in ataxia-telangiectasia.

  2. Nature Genetics, []

Download references


Rights and permissions

Reprints and Permissions

About this article

Cite this article

Weitzman, J.B. ATM splicing defect. Genome Biol 3, spotlight-20020314-01 (2002).

Download citation

  • Published:

  • DOI:


  • Cystic Fibrosis
  • Online Publication
  • Genomic Context
  • Cancer Predisposition
  • Cystic Fibrosis Transmembrane Regulator